子類別 期刊論文 [82/82] 圖書 [5/6] 會議論文/會議摘要 [14/17] 鄰近社群 MARK LAWRENCE WAHLQVIST(2008-2012) [138/140] 吳易謙 [54/55] 吳秀英 [10/10] 廖本揚 [39/39] 廖玉潔 [63/65] 張新儀 [245/268] 李孟智 [51/54] 李蘭 [28/28] 林培生 [25/25] 林煜軒 [47/47] 林肇堂 [35/35] 梁賡義 [15/15] 江博煌 [72/78] 溫啟邦(2001-2010) [177/188] 潘文涵 [110/115] 熊昭 [369/379] 莊淑鈞 [43/44] 莊紹源 [162/168] 蔡慧如 [162/165] 蔡憶文(1999-2010) [34/34] 蕭金福 [188/197] 藍祚運(2003-2011) [22/23] 許志成 [385/393] 邱亞文(2005-2013) [63/99] 邱弘毅 [49/49] 邱燕楓 [82/82] 郭耿南(2003-2010) [89/105] 鍾仁華 [85/86] 陳主智 [61/61] 陳慶餘(2006-2010) [70/70] 陳美惠 [32/32] 陳豐奇 [53/55] 陳麗光 [106/106] 黃國晉 [15/15] 丘政民(2000-2004) [8/8] 其他 [238/244] 劉仁沛(1998-2002) [64/65] 姚姿君(1999-2002) [3/3] 戴東原(2003-2005) [21/22] 李明亮(2003-2007) [6/6] 林仲彥(1999-2005) [31/33] 林錦瑜(2002-2003) [5/5] 涂醒哲(2003-2004) [4/4] 石曜堂(1999-2006) [20/24] 蔡碧紋(2004-2006) [3/4] 陳淑媛(2001-2004) [3/3] 社群統計 近3年內發表的文件:21(20.00%) 含全文筆數:101(96.19%) 文件下載次數統計 下載大於0次:101(100.00%) 下載大於100次:101(100.00%) 檔案下載總次數:45455(0.85%) 最後更新時間: 2024-11-28 11:47 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Establishing and using threshold of... The clinical characteristics and ma... Suppression of the alpha, delta, an... Beyond the waves: Unraveling pandem... Atezolizumab plus bevacizumab for p... Interregional mobility in different... Real-time forecasting of COVID-19 s... Mechanical transmission of dengue v... Screening and identification of emo... Comparison the acute toxicity of tw...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目76-100 / 105. (共5頁) << < 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2012-09	Putative tumor metastasis-associated genes in human gastric cancer	International Journal of Oncology. 2012 Sep;41(3):1068-1084.
2012-09	Weighted evidence approach of bridging study	Journal of Biopharmaceutical Statistics. 2012 Sep;22(5):952-965.
2012-09	Design and analysis issues of multiregional clinical trials with different regional primary endpoints	Journal of Biopharmaceutical Statistics. 2012 Sep;22(5):1051-1059.
2012-07-26	Multiregional Clinical Trials	Design and Analysis of Bridging Studies. 2012 Jul 26;Chapter 11:219-234.
2012-07-26	A bayesian approach for evaluation of bridging studies	Design and Analysis of Bridging Studies. 2012 Jul 26;Chapter 6:89-104.
2012-07-26	Two-stage designs of bridging studies	Design and Analysis of Bridging Studies. 2012 Jul 26;Chapter 2:17-32.
2012-07	Establishing consistency across all regions in a multi-regional clinical trial	Pharmaceutical Statistics. 2012 Jul;11(4):295-299.
2012-06	UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients	Pharmacogenomics. 2012 Jun;13(8):879-888.
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2011-10	Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients	Pharmacogenomics. 2011 Oct;12(10):1397-1406.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.
2011-08	CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer	Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
2011-07	A consistency approach to evaluation of bridging studies and multiregional trials	Statistics in Medicine. 2011 Jul;30(17):2171-2186.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients	Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
2011-04	ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment	Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.
2010-11	CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine	Pharmacogenomics. 2010 Nov;11(11):1535-1543.
2010-07	Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective	Pharmaceutical Statistics. 2010 Jul;9(3):201-206.
2010-07	Sample size determination for a specific region in a multiregional trial	Journal of Biopharmaceutical Statistics. 2010 Jul;20(4):870-885.
2010-05	Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version	Archives of Gerontology and Geriatrics. 2010 May-Jun;50(3):e74-e80.
2009	Statistical validation of traditional Chinese diagnostic procedures	Drug Information Journal. 2009;43(1):83-95.
2009	Translation in clinical technology-traditional Chinese medicine	Translational Medicine: Strategies and Statistical Methods. 2009:205-218.
2008-12	Translation in different diagnostic procedures—traditional Chinese medicine and western medicine	Journal of the Formosan Medical Association. 2008 Dec;107(12, Suppl.1):74-85.

顯示項目76-100 / 105. (共5頁) << < 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目